Skip to content

Frontlight ResearchEarly access

Trial site

Hospital Nacional Dos De Mayo (Site 0905)

Lima, 15087, PeruNot linked to an institution yet

1closed trial

The trials here

What the trial at this site is about, from its registry record.

Conditions: Diffuse large B-cell lymphoma

Closed trials

Recruiting
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
NCT06717347· Phase 3· Merck Sharp & Dohme LLC· Source
Contact: Toll Free Number

Site data: ClinicalTrials.govUpdated 14 Nov 2026

Report an error

Hospital Nacional Dos De Mayo (Site 0905): trial site – Frontlight Research